NU SKIN ENTERPRISES INC - A (NUS)
US67018T1051 - Common Stock
We assign a fundamental rating of 4 out of 10 to NUS. NUS was compared to 37 industry peers in the Personal Care Products industry. NUS has only an average score on both its financial health and profitability. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
NUS had a positive operating cash flow in the past year.
NUS had positive earnings in each of the past 5 years.
NUS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NUS has a Return On Assets (-0.19%) which is in line with its industry peers.
NUS has a Return On Equity (-0.41%) which is in line with its industry peers.
The Return On Invested Capital of NUS (3.21%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for NUS is below the industry average of 13.62%.
The last Return On Invested Capital (3.21%) for NUS is well below the 3 year average (9.55%), which needs to be investigated, but indicates that NUS had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.41% | ||
| ROIC | 3.21% |
ROA(3y)4.65%
ROA(5y)6.71%
ROE(3y)9.62%
ROE(5y)14.02%
ROIC(3y)9.55%
ROIC(5y)11.6%
1.3 Margins
In the last couple of years the Profit Margin of NUS has declined.
NUS has a Operating Margin (3.05%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of NUS has declined.
Looking at the Gross Margin, with a value of 68.42%, NUS is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.05% | ||
| PM (TTM) | N/A | ||
| GM | 68.42% |
OM growth 3Y-29.77%
OM growth 5Y-21.55%
PM growth 3Y-61.1%
PM growth 5Y-37.43%
GM growth 3Y-2.56%
GM growth 5Y-2.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NUS is creating some value.
Compared to 1 year ago, NUS has about the same amount of shares outstanding.
NUS has less shares outstanding than it did 5 years ago.
NUS has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.37 indicates that NUS is not in any danger for bankruptcy at the moment.
The Altman-Z score of NUS (3.37) is better than 67.57% of its industry peers.
The Debt to FCF ratio of NUS is 5.70, which is a neutral value as it means it would take NUS, 5.70 years of fcf income to pay off all of its debts.
NUS has a Debt to FCF ratio (5.70) which is in line with its industry peers.
NUS has a Debt/Equity ratio of 0.56. This is a neutral value indicating NUS is somewhat dependend on debt financing.
The Debt to Equity ratio of NUS (0.56) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 5.7 | ||
| Altman-Z | 3.37 |
ROIC/WACC0.38
WACC8.53%
2.3 Liquidity
A Current Ratio of 2.09 indicates that NUS has no problem at all paying its short term obligations.
NUS has a Current ratio (2.09) which is comparable to the rest of the industry.
NUS has a Quick Ratio of 1.24. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
NUS's Quick ratio of 1.24 is in line compared to the rest of the industry. NUS outperforms 48.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.09 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The earnings per share for NUS have decreased strongly by -37.60% in the last year.
NUS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.77% yearly.
The Revenue has decreased by -9.38% in the past year.
NUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.97% yearly.
EPS 1Y (TTM)-37.6%
EPS 3Y-20.41%
EPS 5Y-13.77%
EPS growth Q2Q-75.68%
Revenue 1Y (TTM)-9.38%
Revenue growth 3Y-8.64%
Revenue growth 5Y-5.97%
Revenue growth Q2Q-13.33%
3.2 Future
The Earnings Per Share is expected to decrease by -7.65% on average over the next years.
NUS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.25% yearly.
EPS Next Y-37.66%
EPS Next 2Y-7.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.29%
Revenue Next 2Y-2.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.75 indicates a reasonable valuation of NUS.
94.59% of the companies in the same industry are more expensive than NUS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.60, NUS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.70, the valuation of NUS can be described as reasonable.
Based on the Price/Forward Earnings ratio, NUS is valued cheaply inside the industry as 94.59% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of NUS to the average of the S&P500 Index (20.15), we can say NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.75 | ||
| Fwd PE | 8.7 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaper than 89.19% of the companies in the same industry.
91.89% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.99 | ||
| EV/EBITDA | 7.14 |
4.3 Compensation for Growth
NUS's earnings are expected to decrease with -7.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.65%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.73%, NUS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.54, NUS pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.32, NUS is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.73% |
5.2 History
The dividend of NUS has a limited annual growth rate of 1.01%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
NUS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.01%
Div Incr Years19
Div Non Decr Years19
5.3 Sustainability
The earnings of NUS are negative and hence is the payout ratio. NUS will probably not be able to sustain this dividend level.
DP-1826.35%
EPS Next 2Y-7.65%
EPS Next 3YN/A
NU SKIN ENTERPRISES INC - A
NYSE:NUS (5/17/2024, 7:16:55 PM)
After market: 13.65 0 (0%)13.65
-0.21 (-1.52%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap677.86M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.73% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.75 | ||
| Fwd PE | 8.7 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.41% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 3.05% | ||
| PM (TTM) | N/A | ||
| GM | 68.42% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.09 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-37.6%
EPS 3Y-20.41%
EPS 5Y
EPS growth Q2Q
EPS Next Y-37.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-9.38%
Revenue growth 3Y-8.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y